Insight (American Society Of Ophthalmic Registered Nurses)[JOURNAL]

Sun 200 papers

RSS

Volunteer networking session at the 2012 meeting: a prescription for renewal.

Burlew JA

Insight · 2013 · PMID 23505794

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Ocular graft vs. host disease after hematopoietic stem cell transplantation.

Rumery TC, Mian SI

Insight · 2013 · PMID 23505793

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Glaucoma medications.

Chae B, Cakiner-Egilmez T, Desai M

Insight · 2013 · PMID 23505792

Glaucoma is a common eye condition that affects millions of individuals worldwide, making it the second-leading cause of blindness. Because glaucoma is associated with increased IOP level, the primary goal in treatment o... Glaucoma is a common eye condition that affects millions of individuals worldwide, making it the second-leading cause of blindness. Because glaucoma is associated with increased IOP level, the primary goal in treatment of glaucoma includes lowering IOP to prevent further progression of the disease. While various surgical interventions exist, medical therapy is currently the first line of treatment. Medical treatment of glaucoma includes topical beta-blockers, alpha-2 agonists, prostaglandins, parasympathomimetics and CAIs. Anti-glaucoma agents help reduce IOP by affecting the production of aqueous humor or increasing the outflow of aqueous through the trabecular or uveoscleral pathway. Choosing an appropriate medical regimen can be challenging and various factors such as efficacy, safety, cost and patient compliance must be considered. First-line treatment is often topical beta-blockers or prostaglandin analogs. However, beta-blocking agents can be associated with systemic side effects and need to be used cautiously in patients with serious concomitant cardiopulmonary disease. Alpha-2 agonists and parasympathomimetics are often considered second- or third-line treatment options but good adjunctive agents. Oral CAIs are often indicated for patients with elevated IOP in an acute setting or for patients resistant to other glaucoma medications and patients who are not good surgical candidates.

Get PDF PubMed ↗

ASORN's internal nursing process.

Waldo MN

Insight · 2013 · PMID 23505791

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

21 ways to retain nurses.

Thieman L

Insight · 2012 · PMID 23256437

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Nighty night sleep tight--health benefits of a good night's sleep.

Whitton S

Insight · 2012 · PMID 23256436

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Sjögren's syndrome: the dry, mysterious illness.

Johnson K

Insight · 2012 · PMID 23256435

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

The best medicine.

Thieman L

Insight · 2012 · PMID 23256434

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

The road to excellence--becoming certified.

Kelly A

Insight · 2012 · PMID 23256433

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Serving the world: Bangladesh eye care.

Timmreck EJ

Insight · 2012 · PMID 23256432

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Scleritis--Wegener's granulomatosis.

Opremcak EM

Insight · 2012 · PMID 23256431

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Ophthalmology and meaningful use.

Smith SC

Insight · 2012 · PMID 23256430

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Carbogen in the management of a central retinal artery occlusion.

Fowler SB

Insight · 2012 · PMID 23256429

Carbogen therapy is a promising treatment aimed at improving retinal oxygenation and subsequent vision. Nurses play a key role in patient education, administration, emotional support, and monitoring of potential side eff... Carbogen therapy is a promising treatment aimed at improving retinal oxygenation and subsequent vision. Nurses play a key role in patient education, administration, emotional support, and monitoring of potential side effects and effectiveness of carbogen as patients hope to regain lost vision.

Get PDF PubMed ↗